FDA — authorised 27 December 2021
- Marketing authorisation holder: LEO PHARMA AS
- Status: approved
🇺🇸 Adbry in United States
FDA authorised Adbry on 27 December 2021
Marketing authorisations
FDA — authorised 27 December 2021
- Application: BLA761180
- Marketing authorisation holder: LEO PHARMA AS
- Local brand name: ADBRY
- Indication: INJECTABLE — INJECTION
- Status: approved
Adbry in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Adbry approved in United States?
Yes. FDA authorised it on 27 December 2021; FDA authorised it on 27 December 2021.
Who is the marketing authorisation holder for Adbry in United States?
LEO PHARMA AS holds the US marketing authorisation.